Next-generation sequencing technology has shown that the exosomal transfer of miR-21 from CAFs to ovarian cancer cells inhibited apoptosis and promoted resistance to paclitaxel treatment by downregulating the expression of apoptotic peptidase activating factor (APAF1) [39]. This evidence concerns the gene APAF1 and ovarian carcinoma.